Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1415-21. doi: 10.1016/j.ijrobp.2010.07.039. Epub 2010 Oct 18.
To evaluate the correlation between the 1993 and 2000/2007 World Health Organization (WHO) classification with the outcome in patients with high-grade meningiomas.
Between 1985 and 2004, 73 patients diagnosed with atypical or anaplastic meningiomas were treated with radiotherapy. Sections from the paraffin-embedded tumor material from 66 patients (90%) from 13 different pathology departments were re-evaluated according to the first revised WHO classification from 1993 and the revised classifications from 2000/2007. In 4 cases, the initial diagnosis meningioma was not reproducible (5%). Therefore, 62 patients with meningiomas were analyzed.
All 62 tumors were reclassified according to the 1993 and 2000/2007 WHO classification systems. Using the 1993 system, 7 patients were diagnosed with WHO grade I meningioma (11%), 23 with WHO grade II (37%), and 32 with WHO grade III meningioma (52%). After scoring using the 2000/2007 system, we found 17 WHO grade I meningiomas (27%), 32 WHO grade II meningiomas (52%), and 13 WHO grade III meningiomas (21%). According to the 1993 classification, the difference in overall survival was not statistically significant among the histologic subgroups (p=.96). Using the 2000/2007 WHO classifications, the difference in overall survival became significant (p=.02). Of the 62 reclassified patients 29 developed tumor progression (47%). No difference in progression-free survival was observed among the histologic subgroups (p=.44). After grading according to the 2000/2007 WHO classifications, significant differences in progression-free survival were observed among the three histologic groups (p=.005).
The new 2000/2007 WHO classification for meningiomas showed an improved correlation between the histologic grade and outcome. This classification therefore provides a useful basis to determine the postoperative indication for radiotherapy. According to our results, a comparison of the published data for future treatment decision-making remains difficult when the histologic diagnosis has not been based on the new improved classification system.
评估 1993 年和 2000/2007 年世界卫生组织(WHO)分类与高级别脑膜瘤患者预后之间的相关性。
1985 年至 2004 年间,73 例诊断为非典型或间变脑膜瘤的患者接受了放疗。从 13 个不同病理科的 66 例患者(90%)的石蜡包埋肿瘤标本中,选取 66 例患者的肿瘤组织进行了再次评估,评估依据为 1993 年首次修订的 WHO 分类和 2000/2007 年修订的分类。在 4 例中,最初的脑膜瘤诊断不可重复(5%)。因此,共分析了 62 例脑膜瘤患者。
所有 62 例肿瘤均根据 1993 年和 2000/2007 年 WHO 分类系统进行了重新分类。根据 1993 年系统,7 例诊断为 WHO 分级 I 型脑膜瘤(11%),23 例诊断为 WHO 分级 II 型(37%),32 例诊断为 WHO 分级 III 型脑膜瘤(52%)。根据 2000/2007 年系统评分,我们发现 17 例为 WHO 分级 I 型脑膜瘤(27%),32 例为 WHO 分级 II 型(52%),13 例为 WHO 分级 III 型脑膜瘤(21%)。根据 1993 年的分类,组织学亚组之间的总生存率差异无统计学意义(p=0.96)。而使用 2000/2007 年 WHO 分类,总生存率差异有统计学意义(p=0.02)。在 62 例重新分类的患者中,有 29 例出现肿瘤进展(47%)。组织学亚组之间无无进展生存率差异(p=0.44)。根据 2000/2007 年 WHO 分类分级后,三组之间的无进展生存率差异有统计学意义(p=0.005)。
新的 2000/2007 年 WHO 脑膜瘤分类显示组织学分级与预后之间的相关性有所提高。因此,该分类为确定术后放疗的适应证提供了有用的依据。根据我们的结果,当组织学诊断未基于新的改良分类系统时,比较发表的数据进行未来的治疗决策仍然困难。